Malaysia vs Sur: Estimated antiretroviral therapy coverage among children
Malaysia
87
in 2025
Sur
20
in 2024
Malaysia rank
3rd
Sur rank
1st
Estimated antiretroviral therapy coverage among children over time
- Malaysia
- Sur
How they compare
Malaysia currently reports 87 against 20 in Sur, a difference of 67.
That makes Malaysia's figure about 4.3 times Sur's.
Across all 25 years both countries report, Malaysia has been ahead every year.
Malaysia ranks 3rd and Sur ranks 1st of 89 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.1 | 17.3 | 42.8 | Malaysia |
| 2010s | 76.8 | 40.9 | 35.9 | Malaysia |
| 2020s | 75.2 | 26.6 | 48.6 | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Malaysia or Sur?
- Malaysia, at 87 against 20 in Sur as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among children between Malaysia and Sur?
- 67, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Sur?
- 25 years are reported by both, from 2000 to 2024.
- How do Malaysia and Sur rank globally for estimated antiretroviral therapy coverage among children?
- Malaysia ranks 3rd and Sur ranks 1st of 89 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.